287 related articles for article (PubMed ID: 25562591)
1. Determinants of patient-rated and clinician-rated illness severity in schizophrenia.
Fervaha G; Takeuchi H; Agid O; Lee J; Foussias G; Remington G
J Clin Psychiatry; 2015 Jul; 76(7):924-30. PubMed ID: 25562591
[TBL] [Abstract][Full Text] [Related]
2. Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia.
Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Remington G
J Clin Psychopharmacol; 2015 Apr; 35(2):128-33. PubMed ID: 25679125
[TBL] [Abstract][Full Text] [Related]
3. Motivational deficits and cognitive test performance in schizophrenia.
Fervaha G; Zakzanis KK; Foussias G; Graff-Guerrero A; Agid O; Remington G
JAMA Psychiatry; 2014 Sep; 71(9):1058-65. PubMed ID: 25075930
[TBL] [Abstract][Full Text] [Related]
4. The discrepancy between patients and informants on clinician-rated measures in major depressive disorder: implications for clinical trials and clinical practice.
Peselow ED; Karamians R; Lord M; Tobia G; IsHak WW
Int Clin Psychopharmacol; 2014 Mar; 29(2):111-5. PubMed ID: 24216755
[TBL] [Abstract][Full Text] [Related]
5. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
[TBL] [Abstract][Full Text] [Related]
6. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
7. Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.
Lysaker PH; Weiden PJ; Sun X; O'Sullivan AK; McEvoy JP
BMC Psychiatry; 2022 Aug; 22(1):574. PubMed ID: 36031632
[TBL] [Abstract][Full Text] [Related]
8. Linking the PANSS, BPRS, and CGI: clinical implications.
Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
[TBL] [Abstract][Full Text] [Related]
9. Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.
Ventura J; Cienfuegos A; Boxer O; Bilder R
Schizophr Res; 2008 Nov; 106(1):59-69. PubMed ID: 17900866
[TBL] [Abstract][Full Text] [Related]
10. Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data.
Takeuchi H; Fervaha G; Uchida H; Suzuki T; Bies RR; Grönte D; Remington G
J Clin Psychiatry; 2014 May; 75(5):506-11. PubMed ID: 24569099
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
12. Clinician-rated functioning and patient-rated quality of life in schizophrenia: implications of their correspondence for psychopathology and side effects.
Jung HY; Hwang SS; Yi JS; Kim Y; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):225-30. PubMed ID: 19931586
[TBL] [Abstract][Full Text] [Related]
13. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
[TBL] [Abstract][Full Text] [Related]
14. Concordance of self-rated and observer-rated dysphoric symptoms in mania.
Cassidy F; Ahearn E; Carroll BJ
J Affect Disord; 2009 Apr; 114(1-3):294-8. PubMed ID: 18684512
[TBL] [Abstract][Full Text] [Related]
15. To what extent do the PANSS and CGI-S overlap?
Rabinowitz J; Mehnert A; Eerdekens M
J Clin Psychopharmacol; 2006 Jun; 26(3):303-7. PubMed ID: 16702895
[TBL] [Abstract][Full Text] [Related]
16. Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
Weisler RH; Babcock T; Adeyi B; Brams M
Postgrad Med; 2014 Sep; 126(5):31-41. PubMed ID: 25295648
[TBL] [Abstract][Full Text] [Related]
17. Generalized anxiety disorder in older adults: examining the relation between clinician severity ratings and patient self-report measures.
Hopko DR; Bourland SL; Stanley MA; Beck JG; Novy DM; Averill PM; Swann AC
Depress Anxiety; 2000; 12(4):217-25. PubMed ID: 11195758
[TBL] [Abstract][Full Text] [Related]
18. Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome: Associations With Quality of Life and Depression.
Pasch L; He SY; Huddleston H; Cedars MI; Beshay A; Zane LT; Shinkai K
JAMA Dermatol; 2016 Jul; 152(7):783-8. PubMed ID: 26942548
[TBL] [Abstract][Full Text] [Related]
19. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
[TBL] [Abstract][Full Text] [Related]
20. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
